Amantadine-induced livedo racemosa

BMJ Case Rep. 2024 Jan 12;17(1):e257492. doi: 10.1136/bcr-2023-257492.
No abstract available

Keywords: Dermatology; Drugs and medicines; General practice / family medicine; Parkinson's disease; Unwanted effects / adverse reactions.

Publication types

  • Case Reports

MeSH terms

  • Amantadine / adverse effects
  • Antiparkinson Agents / adverse effects
  • Humans
  • Livedo Reticularis*
  • Parkinson Disease*

Substances

  • Amantadine
  • Antiparkinson Agents